Greater Munich Area: Freising-Munich-Martinsried

The well-functioning network of science, industry and politics provides the biotechnology companies with a decisive locational advantage that has enabled the Munich BioTech Region to develop into Germany's leading biotechnology cluster. With more than 190 companies and more than 13,000 employees in the Life Science sector, and with two universities (which just recently joined the ranks of Germany's elite universities), two universities of applied sciences, the Max Plank Institutes of Biochemistry, Neurobiology and Psychiatry, the Helmholtz Research Center for Environmental Health, as well as further renowned institutes and organizations, the region offers an outstanding environment for innovations.

The small and medium-sized biotechnology companies focus on so-called “red biotechnology”, especially on research and development in the field of diagnostics and therapeutics. Small and medium sized enterprises (SMEs) from Munich are at the very forefront of drug development throughout Germany – two products from MediGene have received marketing approval, further products have already been approved in other countries and are expected to receive approval in Germany in 2008. Eight companies are listed on the stock exchange, among them MorphoSys, one of the region's largest companies and one of those with the highest turnover.

Your gateway to Munich Biotech: www.bio-m.org